Buntyn et al., 2016 - Google Patents
Effects of Feeding OmniGen-AF® on Immune Function, Performance, and Carcass Characteristics during the Feeding PeriodBuntyn et al., 2016
View PDF- Document ID
- 8631101373310837419
- Author
- Buntyn J
- Sieren S
- Bittner Bittner C
- Burken D
- Erickson G
- Burdick Sanchez N
- Carroll J
- Jones S
- Schmidt T
- Dehann K
- Wistuba T
- et al.
- Publication year
External Links
Snippet
Abstract OmniGen-AF (Phibro Animal Health, Quincy, IL) was fed to steers to evaluate the effects on the metabolic and immune response during an immune challenge, as well as feedlot performance. Th e inclusion of OmniGen-AF for either the first 28 d or the entire …
- 230000000694 effects 0 title abstract description 11
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11419888B2 (en) | Composition and method for promoting reduction of heat stress in animals | |
Schubach et al. | Impacts of stocking density on development and puberty attainment of replacement beef heifers | |
Hosseini et al. | Determining optimum age of Holstein dairy calves when adding chopped alfalfa hay to meal starter diets based on measures of growth and performance | |
Brown et al. | Invited review: Mechanisms of hypophagia during disease | |
Lippolis et al. | Physiologic, health, and performance responses of beef steers supplemented with an immunomodulatory feed ingredient during feedlot receiving | |
Buntyn et al. | Effects of Feeding OmniGen-AF® on Immune Function, Performance, and Carcass Characteristics during the Feeding Period | |
Kehoe et al. | Influence of nonmedicated additives as alternatives to antibiotics on calf growth and health | |
Qureshi et al. | An apparent effect of immunopotentiation during late gestation on the postpartum reproductive performance of Nili-Ravi buffaloes (Bubalus bubalis) | |
JP2007538090A (en) | Transfer factor encapsulation composition and method of use | |
Ghasemi-Panahi et al. | New technique for activating reproductive system during non-breeding season in Ghezel ewes | |
Brooks et al. | Ethnoveterinary application of Morinda citrifolia fruit puree on a commercial heifer rearing facility with endemic salmonellosis | |
Thomson et al. | Effects of timing of chlortetracycline in combination with decoquinate on growth performance, health, and carcass characteristics of feeder steers | |
Lopreiato et al. | Maternal treatment with pegbovigrastim influences growth performance and immune-metabolic status of calves during the pre-weaning period | |
Archer | Reducing stress in sheep by feeding the seaweed Ascophyllum nodosum | |
Young | Yeast cell wall supplementation alters the performance and health of newly received crossbred heifers | |
Shadnoush et al. | Effects of restricted feeding and re-feeding in growing lambs: intake, growth and body organs development | |
Lippolis | Management Strategies to Improve Immune Function and Performance of Feeder Cattle | |
Buntyn et al. | Yeast supplementation alters the immune response in feedlot steers | |
Rivera et al. | Effects of graded levels of vitamin E on inflammatory response and evaluation of methods of supplementing vitamin E on performance and health of beef steers | |
Gonzalez-Vizcarra et al. | Effects of combining recombinant bovine growth hormone and anabolic implants on growth performance and dietary energetics of Holstein bull calves fed finishing diets | |
LIPOPOLYSACCHARIDE | EFFECTS OF FEEDING SACCHAROMYCES CEREVISIAE FERMENTATION PRODUCTS ON THE HEALTH OF HOLSTEIN DAIRY CALVES FOLLOWING A LIPOPOLYSACCHARIDE CHALLENGE | |
Wilson et al. | Impact of ramaekers immune primer on finishing beef cattle performance and liver abscess rate | |
Crossland et al. | Effects of heat load and active dry yeast supplementation on ruminal parameters | |
Gott et al. | 564 Effects of Biofix® Plus PRO supplemented in liquid feed on the performance of cow-calf pairs in south central Florida | |
Oh et al. | Effect of rumen-protected Capsicum oleoresin on immune responses in lactating dairy cows experimentally challenged with lipopolysaccharide |